Leonard, J., Kaempf, A., Lachowiez, C., Traer, E., Desai, A., Gandhi, A., Saultz, J., Meyers, G., Maziarz, R., Cook, R., Newell, L., Chandra, D., Braun, T., Misra, S., Sheldon, G., Heavner, M. E., Guiducci, L., Messan, T., Park, B., Hayes-Lattin, B., Swords, R. (2025). Venetoclax in combination with dasatinib, prednisone, rituximab and blinatumomab for the upfront treatment of adults with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), Results from a Phase 1B study. Blood. https://doi.org/10.1182/blood-2025-3354